Item 2.02 - Results of Operations and Financial Condition: The Clorox Company issued a press release on August 3, 2026, announcing financial results for its fourth quarter and fiscal year ended June 30, 2026 Item 7.01 - Regulation FD Disclosure: The filing includes disclosure of information being furnished to investors in accordance with Regulation FD Item 9.01 - Financial Statements and…

Our analysis rates this filing BEARISH. Clorox faces a HIGH concern environment (7.2/10) driven by converging operational and demand challenges. The 13% organic sales decline (excluding ERP impact) combined with 42% EPS decline represents a material earnings miss relative to expectations. The 520…

Concern level: HIGH (7.2/10). Key factors: Four new high-severity risks identified with average severity 6.25/10, including organic sales decline of 13% in Q4 and gross margin compression of 520 basis points; Material earnings miss: Adjusted EPS decreased 42% YoY with ~$0.90 impact from ERP-related shipment comparisons, indicating significant underlying demand weakness beyond temporary…

Notable risk changes: Material organic sales decline of 13% in Q4 (excluding ERP impact of 13.5 points) signals underlying demand weakness beyond temporary disruptions. CEO acknowledges 'continued consumer and macroeconomic pressures' and company must 'work to return to organic sales growth' - no near-term recovery expected.; Gross margin compressed 520 basis points in Q4 to 41.3%, driven by GOJO inventory step-up…

The model predicts CLX will underperform the S&P 500 by about 0.0% over 30 days (model confidence 50%). This is model analysis for research, not investment advice.